Literature
(1) Aoyagi, T. et al. (1971) J. Antibiotics 24, 687-694. Effect of Pepstatin on acid proteases. (2) Umezawa, H. (1976) Methods Enzymol. 45, 678-695. Structures and activities of protease inhibitors of microbial origin. (3) Katoh, I. et al. (1987) Nature 329, 654-656. Inhibition of retroviral protease activity by an aspartyl proteinase inhibitor. (4) Von der Helm, K. et al. (1989) FEBS Lett. 247, 349-352. Inhibition of HIV replication in cell culture by the specific aspartic protease inhibitor Pepstatin A. (5) Menéndez-Arias, L. et al. (1992) J. Biol. Chem. 267, 24134-24139. Purification and characterization of the MMTV protease expressed in Escherichia coli. (6) Saiga, A. et al. (1993) Arch. Virol. 128, 195-210. The HTLV-1 protease expressed in Escherichia coli possesses aspartic proteinase activity.
